Description: Panelists lead participants in a discussion of recent experiences and current issues regarding the valuation of medical and dental insurance and managed care products. Topics include ASOP 22 [asset adequacy analysis for statements of actuarial opinion] and ASOP 41 [communication]. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 102

Description: Panel discusses the effects of reduced payment levels to many Medicare managed care organizations. From the Record of the Society of Actuaries, Vol. 24, No. 2.

Description: This 1992 panel discussion is about regulations proposed or adopted by the NAIC, the Health Insurance Association of America [HIAA], and states to regulate small group underwriting and rate guidelines. From the Record of the Society of Actuaries Vol. 18, No. 1A.

Description: 1993 SOA Spring Meeting, San Diego. This session discussed credibility theory. Areas addressed included defining credibility and the complexities of measuring it with an emphasis on group medical insurance.

Description: Discusses health-care-cost reimbursement structures, from the facility/hospital perspective and the professional/doctor perspective. Also discusses risk-absorption methods. From the 1987 Record of Society of Actuaries, Vol. 13, No. 1.

Description: Table of Contents for the 1987 Record of Society of Actuaries, Vol. 13, No. 1, about the April Society of Actuaries Meeting on Health Insurance in Nashville, Tennessee.

Description: This 1991 panel discussion is about the NAIC and HIAA models, as well as state regulations proposed or adopted to regulate small group underwriting and rate guidelines. From the Record of the Society of Actuaries Vol. 17, No. 3A.

Description: This session discusses the merits of the Small Business Health Fairness Act [an amendment to ERSIA] and the implications of associations sponsoring health plans for small employer groups. From the Record of the Society of Actuaries, Volume 30, No. 1, Session 35

Description: Presented at October 2001 Annual Meeting. Panelists provide insight into the factors driving the cost increase of prescription drugs and how these factors are being addressed. Strategies include drug utilization review, manufacturer contracting, benefit design, formularies, pharmaceutical pricing, therapeutic substitution, physical education, and introduction of new pharmaceuticals. Also discussed are pharmacoeconomic benefit considerations when studying integrated medical and pharmacy expenses.

Description: This session discussion is about pros and cons of the NAIC recommended rate filing guidelines, pros and cons of renewal rating practices of MET and individual major medical business. From Record of Society of Actuaries Vol. 16, No. 1.